AngioDynamics Inc. Reports Fiscal Q4 and FY2026 Results

What Happened
AngioDynamics, Inc. announced its financial results for the fiscal fourth quarter and full year ended May 31, 2026. The company issued a press release and a set of presentation slides on July 14, 2026; both documents were furnished to the SEC as Exhibits 99.1 and 99.2 to the Form 8-K (Items 2.02 and 7.01).

Key Details

• The 8-K was filed July 14, 2026 and covers results for the fiscal fourth quarter and full year ended May 31, 2026.
• Exhibit 99.1: Press release dated July 14, 2026 (financial results announcement).
• Exhibit 99.2: Presentation slides dated July 14, 2026 discussing the quarter and full-year results.
• Items reported on the Form 8-K: 2.02 (Results of Operations and Financial Condition) and 7.01 (Regulation FD Disclosure).

Why It Matters
This filing signals that AngioDynamics has released its latest earnings and supporting presentation—key sources for revenue, profitability, cash flow and any management commentary or guidance. Retail investors should read the press release and slides (Exhibits 99.1 and 99.2) to see the reported revenue, earnings (or loss), segment trends, and any forward-looking commentary that could affect the stock. The Form 8-K itself furnishes those documents but does not restate the financial figures; review the exhibits for the full financial details.